A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients
Clinical trial NCT02649218 · COMPLETED
Trial details
- NCT number
- NCT02649218
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-24
- Primary completion
- 2019-05-02
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.